Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0814 European financing
BioCentury & Getty Images

Finance

Non-European venture investment in European biotech is on the rise

BioCentury breaks down three years of venture financings in Europe by investor geography

BioCentury breaks down three years of biotech venture financings in Europe by investor geography, company stage and round type.

Aug 14, 2020 | 5:20 PM GMT

European biotechs are seeing more participation by non-European investors in venture rounds than they’ve seen in the last three years, and the median size of the financings has outstripped solely domestic rounds.

BioCentury analyzed 133 European venture financings between Jan. 1, 2017 and June 30, 2020 that raised at least $25 million and found a steep rise in cross-border interest in the first half of 2020.

The question is

Read the full 1181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE